Aptuit LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aptuit LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013091
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aptuit LLC (Aptuit) is a provider of drug discovery and development services. The company offer wide range of services such as manufacturing, project management, small and large molecules analysis, formulation development, integrated chemistry, API route scouting and process development, consultancy, immunology and biomarkers, pharmacology, drug metabolism and pharmacokinetics. Aptuit spans its expertise in the therapeutic areas of neuroscience, antibacterial, oncology, and respiratory. The company has partnership with Welsh, Carson, Anderson & Stowe. It serves pharmaceutical and biotechnology companies. The company operates in the US, Italy, Switzerland and the UK among others. Aptuit is headquartered in Greenwich, Connecticut, the US.

Aptuit LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aptuit LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bioversys and Aptuit Enter into Partnership 10
Dementia Discovery Fund and Aptuit Enter into Partnership 11
Aptuit Enters into Agreement with Massachusetts General Hospital 12
Chronos Therapeutics Partners with Aptuit 13
Aptuit Enters into Agreement with Chiesi Farmaceutici 14
Aptuit Enters into Agreement with Dimension Therapeutics 15
Icagen Partners with Aptuit 16
SAMDI Tech Enters into Agreement with Exquiron 17
Asset Transactions 18
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 18
Acquisition 19
Evotec Acquires Aptuit for USD300 Million 19
Aptuit Acquires Kuecept 21
Aptuit Acquires Exquiron Biotech 22
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 23
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 24
Aptuit LLC – Key Competitors 25
Aptuit LLC – Key Employees 26
Aptuit LLC – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Recent Developments 29
Corporate Communications 29
Apr 06, 2017: Aptuit Announces Alignment of Organizational Structure to Integrated Solution Delivery: Henning Steinhagen Appointed as President, Research and Development Operations 29
Nov 28, 2016: Aptuit Names Peter Gray as the New Chairman of Aptuit Holdings 30
Nov 28, 2016: Aptuit appoints new chairman 31
Oct 13, 2016: Aptuit Announces Enhancement of Integrated IND Enabling Services 32
Aug 01, 2016: Tim Tyson to leave as Chairman of Aptuit 33
Other Significant Developments 34
Nov 30, 2016: Aptuit completes expansion of compound screening library 34
Nov 29, 2016: Aptuit Announces Expansion of Compound Library 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Aptuit LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptuit LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bioversys and Aptuit Enter into Partnership 10
Dementia Discovery Fund and Aptuit Enter into Partnership 11
Aptuit Enters into Agreement with Massachusetts General Hospital 12
Chronos Therapeutics Partners with Aptuit 13
Aptuit Enters into Agreement with Chiesi Farmaceutici 14
Aptuit Enters into Agreement with Dimension Therapeutics 15
Icagen Partners with Aptuit 16
SAMDI Tech Enters into Agreement with Exquiron 17
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 18
Evotec Acquires Aptuit for USD300 Million 19
Aptuit Acquires Kuecept 21
Aptuit Acquires Exquiron Biotech 22
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 23
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 24
Aptuit LLC, Key Competitors 25
Aptuit LLC, Key Employees 26
Aptuit LLC, Other Locations 27
Aptuit LLC, Subsidiaries 27
Aptuit LLC, Joint Venture 27

★海外企業調査レポート[Aptuit LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Metgasco Ltd (MEL):企業の財務・戦略的SWOT分析
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • The Mosaic Company:企業の戦略・SWOT・財務情報
    The Mosaic Company - Strategy, SWOT and Corporate Finance Report Summary The Mosaic Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Korea Electric Power Corporation:企業のM&A・事業提携・投資動向
    Korea Electric Power Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Korea Electric Power Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Lockheed Martin Corporation:戦略・SWOT・企業財務分析
    Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • EarLens Corp:医療機器:M&Aディール及び事業提携情報
    Summary EarLens Corp (EarLens) is engaged in designing and manufacturing of hearing aid products for hearing impaired patients. Its lead product Earlens Hearing Aid is a hearing device that utilizes light to transmit sound. The device automatically adjusts to noisy environments and delivers the broa …
  • A.P. Moller – Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    A.P. Moller - Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry …
  • China Aviation Oil (Singapore) Corp Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Versantis AG-製薬・医療分野:企業M&A・提携分析
    Summary Versantis AG (Versantis), is a preclinical stage pharmaceutical company which offers new medicines and diagnostics for treating liver diseases. It’s lead pipeline product VS-01, capable of removing toxic agents from the organism and save patients from prescription and illicit drug overdoses. …
  • Bruel & Kjaer Sound & Vibration Measurement AS:企業の戦略・SWOT・財務情報
    Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report Summary Bruel & Kjaer Sound & Vibration Measurement AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Lianhe Chemical Technology Co., Ltd. (002250):企業の財務・戦略的SWOT分析
    Lianhe Chemical Technology Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Datang International Power Generation Co Ltd:発電所・企業SWOT分析
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • T3D Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary T3D Therapeutics Inc (T3D Therapeutics) is a drug discovery company that develops solutions for the treatment of Alzheimer’s disease and Mild Cognitive Impairment. The company’s pipeline product include T3D-959 an optimal disease remedial therapeutic for the treatment of Alzheimer’s disease. …
  • CBS Corporation:戦略・SWOT・企業財務分析
    CBS Corporation - Strategy, SWOT and Corporate Finance Report Summary CBS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Banque Profil de Gestion SA:企業の戦略・SWOT・財務情報
    Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report Summary Banque Profil de Gestion SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆